Peter A. van Dam

10.5k citations

186 papers · 7.2k indexed · 1 hit paper · h-index 49

Impact in

Cancer Research top 0.5%
- Cancer Genomics and Diagnostics
- Breast Cancer Treatment Studies
- Cancer-related molecular mechanisms research
Oncology top 0.5%
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers

Papers in

Cancer Research 75
- Breast Cancer Treatment Studies 33
- Cancer Genomics and Diagnostics 20
Oncology 104
- Cancer Cells and Metastasis 30
- Cancer Immunotherapy and Biomarkers 16

Co-authors: Luc Dirix Steven Van Laere Peter Vermeulen Ilse Van der Auwera Ina Benoy Wiebren Tjalma Eric A. Van Marck Gert G. Van den Eynden
Journals: British Journal of Cancer (19 papers)International Journal of Gynecological Cancer (11 papers)European Journal of Obstetrics & Gynecology and Reproductive Biology (9 papers)Clinical Cancer Research (8 papers)Cancer Research (8 papers)
Partner nations: Belgium United Kingdom United States

In The Last Decade

Peter A. van Dam

179 papers receiving 7.1k citations

Hit Papers

align trajectories log scale

The potential and controversy of targeting STAT family members in cancer 2019 · 273 citations

Peers

Countries citing papers authored by Peter A. van Dam

Since Specialization

Citations

This map shows the geographic impact of Peter A. van Dam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter A. van Dam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter A. van Dam more than expected).

Fields of papers citing papers by Peter A. van Dam

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter A. van Dam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter A. van Dam. The network helps show where Peter A. van Dam may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Peter A. van Dam, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter A. van Dam Line = papers co-authored together Peter A. van Dam links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Clinico-pathological features predicting indication to mastectomy in breast cancer patients achieving complete response after neoadjuvant therapy: A retrospective analysis of the EUSOMA database European Journal of Surgical Oncology ·Giuseppe Catanuto, Damiano Gentile, Federica Martorana, Mariano Tomatis, Antonio Ponti, Lorenza Marotti, Cynthia Aristei, Maria João Cardoso, Kwok‐Leung Cheung, Giuseppe Curigliano, Jakob de Vries, Andreas Karakatsanis, Donatella Santini, Francesco Sardanelli, Peter A. van Dam, Isabel T. Rubio, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	2025	2
2	Uptake of post-mastectomy immediate breast reconstruction in older women – A real-world analysis from the European Society of Breast Cancer Specialists (EUSOMA) certified breast centres European Journal of Cancer ·Heni Sumastri, Ruth Parks, Lorenza Marotti, Antonio Ponti, Mariano Tomatis, Cynthia Aristei, Giuseppe Curigliano, Jakob de Vries, Donatella Santini, Francesco Sardanelli, Peter A. van Dam, Isabel T. Rubio, Maria João Cardoso, Kwok‐Leung Cheung	2024	0
3	Axillary surgery trends for breast cancer after neoadjuvant treatment: a report from the EUSOMA multi-institutional European database European Journal of Surgical Oncology ·Antonio Esgueva, Mariano Tomatis, Antonio Ponti, Lorenza Marotti, Iwaniak Anna, Maria João Cardoso, Kwok‐Leung Cheung, Jakob de Vries, Peter A. van Dam, Isabel T. Rubio	2024	0
4	Association between hospital volume and outcomes in invasive ovarian cancer in Belgium: A population-based study European Journal of Cancer ·Isabelle Savoye, Geert Silversmit, Jolyce Bourgeois, Cindy De Gendt, Roos Leroy, Georges Amon, Sabine Stordeur, P. De Sutter, Frédéric Goffin, Mathieu Luyckx, 褚玉梅, Peter A. van Dam, Toon Van Gorp, Leen Verleye	2023	1
5	Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy in patients with advanced ovarian cancer (OVHIPEC-1): final survival analysis of a randomised, controlled, phase 3 trial The Lancet Oncology ·S. Lot Aronson, Marta López‐Yurda, Simone N. Koole, Jules H. Schagen van Leeuwen, Sam Pullman, Ralph H.M. Hermans, Ignace H. J. T. de Hingh, Mignon D J M van Gent, Henriëtte J.G. Arts, Maaike A. van der Aa, Peter A. van Dam, Peter Vuylsteke, Arend G. J. Aalbers, Victor J. Verwaal, Koen Van de Vijver, Neil K. Aaronson, Gabe S. Sonke, Willemien J. van Driel	2023	55
6	2022-RA-638-ESGO Pembrolizumab with multimodal immunomodulation in chemotherapy-pretreated cervical, endometrial, and uterine cancer: the PRIMMO phase II trial International Journal of Gynecological Cancer ·Emiel A. De Jaeghere, Sandra Tuyaerts, Elmer F. Chapman, Ann Belmans, Kris Bogaerts, C. Mattheck, Peter Vuylsteke, Stéphanie Henry, Xuan Bich Trinh, Peter A. van Dam, Sandrine Aspeslagh, Helen van Dam-Nolen, Eline Naert, Diether Lambrechts, An Hendrix, Olivier De Wever, Koen Van de Vijver, Frédéric Amant, Katrien Vandecasteele, Hannelore Denys	2022	0
7	Quality indicators for the management of epithelial ovarian cancer Isabelle Savoye, Cindy De Gendt, Jolyce Bourgeois, Georges Amon, Roos Leroy, Geert Silversmit, Sabine Stordeur, Liesbet Van Eycken, Cécile Colpaert, P. De Sutter, Hannelore Denys, Frédéric Goffin, K. Christopher Beard, Mathieu Luyckx, 褚玉梅, D. Timmerman, Peter A. van Dam, Toon Van Gorp, Geert Villeirs, Leen Verleye	2022	0
8	Improved Characteristics of RANKL Immuno-PET Imaging Using Radiolabeled Antibody Fab Fragments Pharmaceutics ·Sergio Perillo, 和幸盛田, B Meister, Isabel Pintelon, Christel Vangestel, José Sereno, Peter A. van Dam, Antero Abrunhosa, Filipe Elvas, Tim Van den Wyngaert	2022	5
9	Cancer-Associated Fibroblasts as a Common Orchestrator of Therapy Resistance in Lung and Pancreatic Cancer Cancers ·Andreas Domen, Delphine Quatannens, Sara Zanivan, Christophe Deben, Jonas R.M. Van Audenaerde, Evelien Smits, An Wouters, Filip Lardon, Geert Roeyen, Yannick Verhoeven, Annelies Janssens, Timon Vandamme, Peter A. van Dam, Marc Peeters, Hans Prenen	2021	42
10	The Evolution and Prognostic Role of Tumour-Infiltrating Lymphocytes and Peripheral Blood-Based Biomarkers in Inflammatory Breast Cancer Patients Treated with Neoadjuvant Chemotherapy Cancers ·Christophe Van Berckelaer, Maria Aline Barros Fidelis de Moura, Pierre Chomel, François Sant’Angelo, Gizem Öner, Xuan Bich Trinh, Wiebren Tjalma, Glenn Broeckx, Emmanuelle Charafe‐Jauffret, Steven Van Laere, François Bertucci, Cécile Colpaert, Peter A. van Dam	2021	11
11	The art of obtaining a high yield of cell-free DNA from urine PLoS ONE ·pDanielle Fern, Eyram Schwinger, Laure Sorber, Peter A. van Dam, Geert Roeyen, Marc Peeters, Alex Vorsters, An Wouters, Jo Raskin, Christian Rolfo, Karen Zwaenepoel, Patrick Pauwels	2020	43
12	Triple‐negative breast cancer—Role of immunology: A systemic review The Breast Journal ·Gizem Öner, Sevilay Altıntaş, Zafer Cantürk, Wiebren Tjalma, Yannick Verhoeven, Christophe Van Berckelaer, Zwi Berneman, Marc Peeters, Patrick Pauwels, Peter A. van Dam	2019	41
13	Preoperative ultrasound staging of the axilla make’s peroperative examination of the sentinel node redundant in breast cancer: saving tissue, time and money European Journal of Obstetrics & Gynecology and Reproductive Biology ·Christophe Van Berckelaer, Manon Huizing, Mireille Van Goethem, Richard Alexander Wiradinata, Konstantinos Papadimitriou, I. Verslegers, S Aswin Kumar, Peter A. van Dam, Sevilay Altıntaş, Tim Van den Wyngaert, ZERRİN AŞCI, Vasiliki Siozopoulou, Wiebren Tjalma	2016	8
14	Detection and prognostic significance of circulating tumour cells in patients with metastatic breast cancer according to immunohistochemical subtypes British Journal of Cancer ·Dieter Peeters, Pieter‐Jan van Dam, Gary Lewin, Annemie Rutten, Ruth Farrimond-Goff, Lieven Pouillon, Marc Peeters, Patrick Pauwels, Steven Van Laere, Peter A. van Dam, Peter Vermeulen, Luc Dirix	2013	59
15	Gene expression profiles of inflammatory breast cancer: correlation with response to neoadjuvant chemotherapy and metastasis-free survival Annals of Oncology ·François Bertucci, Naoto T. Ueno, Pascal Finetti, Peter Vermeulen, Anthony Lucci, Fredika M. Robertson, Milton Acosta B, Takayuki Iwamoto, (unknown), Hiroko Masuda, Peter A. van Dam, Wendy A. Woodward, Massimo Cristofanilli, James M. Reuben, Luc Dirix, Patrice Viens, W. Fraser Symmans, Daniel Birnbaum, Steven Van Laere	2013	77
16	Gene Expression Profiles Associated with the Presence of a Fibrotic Focus and the Growth Pattern in Lymph Node–Negative Breast Cancer Clinical Cancer Research ·Gert G. Van den Eynden, Marcel Smid, Steven Van Laere, Cécile Colpaert, Ilse Van der Auwera, Jean Michel Vanpeperstraete, Peter A. van Dam, Michael A. den Bakker, Luc Dirix, Eric A. Van Marck, Peter Vermeulen, John A. Foekens	2008	23
17	Relapse-Free Survival in Breast Cancer Patients Is Associated with a Gene Expression Signature Characteristic for Inflammatory Breast Cancer Clinical Cancer Research ·Steven Van Laere, Tim Beißbarth, Ilse Van der Auwera, Gert Van den Eynden, Xuan Bich Trinh, Hilde Elst, Paul Van Hummelen, Peter A. van Dam, Eric Van Marck, Peter Vermeulen, Luc Dirix	2008	24
18	Detection of circulating tumour cells in blood by quantitative real-time RT-PCR: effect of pre-analytical time Clinical Chemistry and Laboratory Medicine (CCLM) ·Ina Benoy, Hilde Elst, Peter A. van Dam, Simon Scharpé, Eric Van Marck, Peter Vermeulen, Luc Dirix	2006	25
19	Angiogenesis and hypoxia in lymph node metastases is predicted by the angiogenesis and hypoxia in the primary tumour in patients with breast cancer British Journal of Cancer ·Gert G. Van den Eynden, Ilse Van der Auwera, Steven Van Laere, Cécile Colpaert, Helen Turley, Adrian L. Harris, Peter A. van Dam, Luc Dirix, Peter Vermeulen, Eric A. Van Marck	2005	48
20	Relative microvessel area of the primary tumour, and not lymph node status, predicts the presence of bone marrow micrometastases detected by reverse transcriptase polymerase chain reaction in patients with clinically non-metastatic breast cancer Breast Cancer Research ·Ina Benoy, Roberto Salgado, Hilde Elst, Peter A. van Dam, Joost Weyler, Eric Van Marck, Simon Scharpé, Peter Vermeulen, Luc Dirix	2005	28

About Peter A. van Dam

Peter A. van Dam is a scholar working on Cancer Research, Oncology, Obstetrics and Gynecology, Reproductive Medicine and Pathology and Forensic Medicine, having authored 186 papers that have together received 7.2k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (33 papers), Cancer Cells and Metastasis (30 papers), Ovarian cancer diagnosis and treatment (26 papers), Endometrial and Cervical Cancer Treatments (23 papers), Cancer Genomics and Diagnostics (20 papers), Cervical Cancer and HPV Research (17 papers), Angiogenesis and VEGF in Cancer (17 papers) and Cancer Immunotherapy and Biomarkers (16 papers). The work is most often cited by research in Cancer Research (2.5k citations), Oncology (3.6k citations), Obstetrics and Gynecology (644 citations), Reproductive Medicine (574 citations) and Immunology (891 citations). Peter A. van Dam has collaborated with scholars based in Belgium, United Kingdom and United States. Frequent co-authors include Luc Dirix, Steven Van Laere, Peter Vermeulen, Ilse Van der Auwera, Peter Vermeulen, Ina Benoy, Wiebren Tjalma, Eric A. Van Marck, Gert G. Van den Eynden and Eric Van Marck. Their work appears in journals such as British Journal of Cancer, International Journal of Gynecological Cancer, European Journal of Obstetrics & Gynecology and Reproductive Biology, Clinical Cancer Research and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact